Titan Pharmaceuticals Inc (OTCQB:TTNP.PK)

0.795
Delayed Data
As of 10:13am ET
 +0.005 / +0.63%
Today’s Change
0.44
Today|||52-Week Range
0.87
+72.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$87.2M

Company Description

Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which is developing proprietary therapeutics primarily for the treatment of serious medical disorders. Its products include Probuphine, ProNeura and Fanapt. The company was founded by Louis R. Bucalo in February 1992 and is headquartered in South San Francisco, CA.

Contact Information

Titan Pharmaceuticals, Inc.
400 Oyster Point Boulevard
South San Francisco California 94080-1921
P:(650) 244-4990
Investor Relations:

Employees

Shareholders

Individual stakeholders12.29%
Mutual fund holders--
Other institutional--

Top Executives

Sunil BhonslePresident, Secretary & Director
Brian CrowleyVice President-Finance
Katherine L. Glassman-BeebeChief Development Officer & Executive VP

To view my watchlist

Not a member yet?

Sign up now for a free account